![]() ![]() To learn more, visit or follow us on LinkedIn. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. BEEMW: Beam Global Equity Warrants Exp - Stock Price, Quote and News - CNBC Beam Global Equity Warrants Exp BEEMW:NASDAQ EXPORT WATCHLIST + LIVE MAD MONEY RT Quote. ![]() Participants may access the webcast by registering online using the following link. Beam Global (BEEM) Income Statement - Yahoo Finance U.S. ET the same day.Ī live webcast of the conference call and related presentation will be available on the Company’s website at An archive of the webcast will be available on the Company’s website for 30 days. ![]() Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2022 financial results after the market closes on Thursday, Mavia press release, which will be available on the Company’s website at Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |